CLOSTRIDIUM DIFFICILE INFECTIONS
Clinical trials for CLOSTRIDIUM DIFFICILE INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE INFECTIONS trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop debilitating gut infection from coming back
Prevention Recruiting nowThis study is testing whether a 14-day course of an investigational oral drug called VE303 can prevent a C. difficile infection from coming back after standard antibiotic treatment. It will enroll 852 people who have just been treated for a C. diff infection and are at high risk …
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTIONS
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention
Last updated Mar 12, 2026 13:51 UTC
-
Scientists track hidden c. diff to stop it from coming back
Knowledge-focused Recruiting nowThis study aims to understand why C. difficile (C. diff) gut infections often come back after treatment. Researchers will follow 100 hospitalized patients with a C. diff infection, collecting stool samples to track exactly how and when the bacteria is cleared from their digestive…
Matched conditions: CLOSTRIDIUM DIFFICILE INFECTIONS
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC